Valeo Financial Advisors LLC cut its holdings in Calumet, Inc. (NASDAQ:CLMT – Free Report) by 2.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 38,568 shares of the oil and gas company’s stock after selling 1,073 shares during the quarter. Valeo Financial Advisors LLC’s holdings in Calumet were worth $608,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Caldwell Sutter Capital Inc. boosted its stake in Calumet by 29.9% in the second quarter. Caldwell Sutter Capital Inc. now owns 19,483 shares of the oil and gas company’s stock valued at $307,000 after acquiring an additional 4,483 shares during the last quarter. O Keefe Stevens Advisory Inc. boosted its stake in Calumet by 12.1% in the second quarter. O Keefe Stevens Advisory Inc. now owns 26,817 shares of the oil and gas company’s stock valued at $423,000 after acquiring an additional 2,903 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in Calumet by 33.5% in the first quarter. Goldman Sachs Group Inc. now owns 465,269 shares of the oil and gas company’s stock valued at $5,900,000 after acquiring an additional 116,777 shares during the last quarter. Adams Asset Advisors LLC boosted its stake in Calumet by 0.9% in the second quarter. Adams Asset Advisors LLC now owns 5,406,271 shares of the oil and gas company’s stock valued at $85,176,000 after acquiring an additional 49,948 shares during the last quarter. Finally, Wasserstein Debt Opportunities Management L.P. boosted its position in shares of Calumet by 3.2% during the second quarter. Wasserstein Debt Opportunities Management L.P. now owns 5,817,012 shares of the oil and gas company’s stock worth $91,647,000 after purchasing an additional 180,197 shares in the last quarter. 34.41% of the stock is owned by institutional investors.
Calumet Stock Up 1.5%
Shares of NASDAQ:CLMT opened at $18.55 on Thursday. Calumet, Inc. has a 12 month low of $7.68 and a 12 month high of $25.29. The company’s fifty day simple moving average is $16.67 and its 200 day simple moving average is $14.62. The firm has a market cap of $1.61 billion, a price-to-earnings ratio of -3.55 and a beta of 0.98.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Calumet in a research report on Wednesday. UBS Group lifted their price target on shares of Calumet from $12.00 to $13.25 and gave the stock a “neutral” rating in a research report on Tuesday, August 12th. Four analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $18.71.
View Our Latest Research Report on CLMT
Calumet Profile
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Read More
- Five stocks we like better than Calumet
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- Market Cap Calculator: How to Calculate Market Cap
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- What is the NASDAQ Stock Exchange?
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Want to see what other hedge funds are holding CLMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Calumet, Inc. (NASDAQ:CLMT – Free Report).
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.